Molecular mechanisms of diabetic coronary dysfunction due to large conductance Ca2+-activated K+ channel impairment

Chinese Medical Journal

Volumn 125, Issue 14, 2012, Pages 2548-2555

  Wang, Ru Xinsg ^a   Shi, Hai Feng ^b   Chai, Qiang ^c   Wu, Ying ^a   Sun, Wei ^a   Ji, Yuan ^a   Yao, Yong ^a   Li, Ku Lin ^a   Zhang, Chang Ying ^a   Zheng, Jie ^a   Guo, Su Xia ^a   Li, Xiao Rong ^a   Lu, Tong ^d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d MAYO CLINIC   (United States)

Author keywords

1 subunit; Coronary artery; Diabetes mellitus; Large conductance Ca2+ activated K+ channel; Patch clamp; Smooth muscle cell

Indexed keywords

CALCIUM ION; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL BETA SUBUNIT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOWN REGULATION; ELECTROPHYSIOLOGY; MALE; NONHUMAN; PATCH CLAMP; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTION; VIDEO MICROSCOPY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ELECTROPHYSIOLOGY; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864271131     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.14.028     Document Type: Article

References (39)

1. Coccheri S. Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs 2007; 67: 997-1026.
2. Lüscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 2003; 108: 1655-1661.
3. Ferguson SC, Blane A, Wardlaw J, Frier BM, Perros P, McCrimmon RJ, et al. Influence of an early-onset age of type diabetes on cerebral structure and cognitive function. Diabetes Care 2005; 28: 1431-1437.
4. Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, et al. INTERHEART Investigators in China. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart 2009; 95: 1857-1864.
5. Jackson WF. Ion channels and vascular tone. Hypertension 2000; 35: 173-178.
6. Tanaka Y, Koike K, Toro L. MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms. J Smooth Muscle Res 2004; 40: 125-153.
7. +channels described by a two-tiered allosteric gating mechanism. J Gen Physiol 2000; 116: 75-100.
8. Knaus HG, Garcia-Calvo M, Kaczorowski GJ, Garcia ML. Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. J Biol Chem 1994; 269: 3921-3924.
9. Jiang Z, Wallner M, Meera P, Toro L. Human and rodent MaxiK channel beta-subunit genes: cloning and characterization. Genomics 1999; 55: 57-67.
10. Dworetzky SI, Boissard CG, Lum-Ragan JT, McKay MC, Post-Munson DJ, Trojnacki JT, et al. Phenotypic alteration of a human BK (hSlo) channel by hSloβ subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase a modulation. J Neurosci 1996; 16: 4543-4550.
11. McManus OB, Helms LM, Pallanck L, Ganetzky B, Swanson R, Leonard RJ. Functional role of the beta subunit of high conductance calcium-activated potassium channels. Neuron 1995; 14: 645-650.
12. Lu T, Zhang DM, Wang XL, He T, Wang RX, Chai Q, et al. Regulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitus. Circ Res 2010; 106: 1164-1173.
13. +channels in coronary artery smooth muscle cells in Zucker diabetic fatty rats. Diabetes 2005; 54: 2155-2163.
14. +channels from arteries of type 2 diabetic Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 2006; 290: H1520-H1527.
15. Borbouse L, Dick GM, Asano S, Bender SB, Dincer UD, Payne GA, et al. Impaired function of coronary BKCa channels in metabolic syndrome. Am J Physiol Heart Circ Physiol 2009; 297: H1629-H1637.
16. Rusch NJ. BK channels in cardiovascular disease: a complex story of channel dysregulation. Am J Physiol Heart Circ Physiol 2009; 297: H1580-H1582.
17. +channels by high glucose. Circ Res 2006; 99: 607-616.
18. Lu T, Ye D, Wang X, Seubert JM, Graves JP, Bradbury JA, et al. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol 2006; 575: 627-644.
19. +channels in the coronary artery smooth muscle cells of Zucker diabetic fatty rats. Biophys J 2008; 95: 5165-5177.
20. +. Am J Physiol Heart Circ Physiol 2007; 293: H152-H159.
21. Wang RX, Chai Q, Lu T, Lee HC. Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity. Cardiovasc Res 2011; 90: 344-352.
22. Wang RX, Jiang WP, Li XR, Lai LH. Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells. Pharmazie 2008; 63: 470-474.
23. 2+indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.
24. Zsembery A, Boyce AT, Liang L, Peti-Peterdi J, Bell PD, Schwiebert EM. Sustained calcium entry through P2X nucleotide receptor channels in human airway epithelial cells. J Biol Chem 2003; 278: 13398-13408.
25. Hou S, Heinemann SH, Hoshi T. Modulation of BKCa channel gating by endogenous signaling molecules. Physiology 2009; 24: 26-35.
26. +channels by β-adrenoceptors in guinea pig urinary bladder smooth muscle. Am J Physiol Cell Physiol 2005; 288: C1255-C1263.
27. 2+-activated potassium (BK) α-subunit but not the BKβ1-subunit leads to progressive hearing loss. PNAS 2004; 101: 12922-12927.
28. Gorini G, Ponomareva O, Shores KS, Person MD, Harris RA, Mayfield RD. Dynamin-1 co-associates with native mouse brain BK(Ca) channels: Proteomics analysis of synaptic protein complexes. FEBS Lett 2010; 584: 845-851.
29. Ghatta S, Nimmagadda D, Xu X, O'Rourke ST. Largeconductance, calcium-activated potassium channels: structural and functional implications. Pharmacol Ther 2006; 110: 103-116.
30. Meier M, Hummel M. Cardiovascular disease and intensive glucose normal in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vasc Health Risk Manag 2009; 5: 859-871.
31. Betteridge DJ. CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone. Fundam Clin Pharmacol 2009; 23: 675-679.
32. Bukiya AN, Liu J, Dopico AM. The BK channel accessory beta1 subunit determines alcohol-induced cerebrovascular constriction. FEBS Lett 2009; 583: 2779-2784.
33. 2+binding to the BKCa channel. J Gen Physiol 2009; 133: 139-150.
34. +channel. Am J Physiol Renal Physiol 2008; 295: F1149-F1157.
35. Dong L, Zheng YM, Van Riper D, Rathore R, Liu QH, Singer HA, et al. Functional and molecular evidence for impairment of calcium-activated potassium channels in type-1 diabetic cerebral artery smooth muscle cells. J Cereb Blood Flow Metab 2008; 28: 377-386.
36. Wrzosek A. Endothelium as target for large-conductance calcium-activated potassium channel openers. Acta Biochim Pol 2009; 56: 393-404.
37. Kim HJ, Lim HH, Rho SH, Bao L, Lee JH, Cox DH, et al. Modulation of the conductance-voltage relationship of the BK Ca channel by mutations at the putative flexible interface between two RCK domains. Biophys J 2008; 94: 446-456.
38. Benhassine N, Berger T. Large-conductance calciumdependent potassium channels prevent dendritic excitability in neocortical pyramidal neurons. Pflugers Arch 2009; 457: 1133-1145.
39. Chung AW, Au Yeung K, Chum E, Okon EB, van Breemen C. Diabetes modulates capacitative calcium entry and expression of transient receptor potential canonical channels in human saphenous vein. Eur J Pharmacol 2009; 613: 114-118.